The DNA methylation signature of EpCAM-/CD49f- breast cancer stem cells correspond with worse clinical severity in basal-like breast cancers
30-Minute Departmental Honors Presentation
Presenter: Paris Langley Rizzo
Pre-Recorded: LINK
IL32 overexpression is driven by DNA hypomethylation and contributes to an extracellular matrix (ECM) remodeling phenotype in EpCAM-/CD49f- enriched breast cancer cells
30-Minute Departmental Honors Presentation
Presenter: Elayne Margaret Benson
Pre-Recorded: LINK